NLGN4X TCR transgenic T cells to treat gliomas.

Saved in:
Bibliographic Details
Title: NLGN4X TCR transgenic T cells to treat gliomas.
Authors: Krämer C; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Kilian M; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Chih YC; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Bioscience, Heidelberg University, Heidelberg, Germany., Kourtesakis A; Faculty of Bioscience, Heidelberg University, Heidelberg, Germany.; Neurology Clinic, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany., Hoffmann DC; Faculty of Bioscience, Heidelberg University, Heidelberg, Germany.; Neurology Clinic, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany., Boschert T; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Bioscience, Heidelberg University, Heidelberg, Germany.; Helmholtz Institute of Translational Oncology (HI-TRON), Mainz, Germany., Koopmann P; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Sanghvi K; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Bioscience, Heidelberg University, Heidelberg, Germany., De Roia A; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Faculty of Bioscience, Heidelberg University, Heidelberg, Germany.; DNA Vector Laboratory, DKFZ, Heidelberg, Germany., Jung S; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jähne K; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Day B; Faculty of Medicine, University of Queensland, Herston, Australia.; Cell and Molecular Biology Department, Sid Faithfull Brain Cancer Laboratory, QIMR Berghofer MRI, Brisbane, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Gardens Point, Australia., Shultz LD; Department of Immunology, The Jackson Laboratory, Bar Harbor, Maine, USA., Ratliff M; Department of Neurosurgery, University Hospital Mannheim, Mannheim, Germany., Harbottle R; DNA Vector Laboratory, DKFZ, Heidelberg, Germany., Green EW; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Will R; Neurology Clinic, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany.; Core Facility Cellular tools, DKFZ, Heidelberg, Germany., Wick W, Platten M; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Helmholtz Institute of Translational Oncology (HI-TRON), Mainz, Germany.; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Bunse L; German Cancer Consortium (DKTK) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology, MCTN, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
Source: Neuro-oncology [Neuro Oncol] 2024 Feb 02; Vol. 26 (2), pp. 266-278.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first